Skip to main content
  • Home
  • Transcatheter Edge-to-Edge Repair: An Assessment of its Long-term Impact on Mitral Regurgitation

Transcatheter Edge-to-Edge Repair: An Assessment of its Long-term Impact on Mitral Regurgitation

Topic:
  • Intervention

Available Credit:

  • 1.00 EBAC

Course Published On:

Course Expiry Date:

Overview

During this programme 'Transcatheter Edge-to-Edge Repair: An Assessment of its Long-term Impact on Mitral Regurgitation', Radcliffe Medical Education bring together an outstanding faculty of international leaders to address how TEER therapy has driven unparalleled clinical outcomes across a diverse group of mitral regurgitation patients over the past two decades.

 

Dr Marta Sitges (University of Barcelona, ES) moderates proceedings, and is joined by Dr Paul Mahoney (Sentara Heart Hospital, US), Prof Francesco Maisano (San Raffaele Hospital, IT) and Dr Anita Asgar (Montreal Heart Institute, CA), for a series of insightful presentations, patient case studies and discussions, which focus on long-term outcomes with TEER and consider the totality of evidence, including real-world data.

Disclosure

In compliance with EBAC guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations. 

The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities. 

Support Statement

This programme is supported by an unrestricted educational grant from Abbott.

Terms & Conditions

Radcliffe Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.

 

The session, ‘Transcatheter Edge-to-Edge Repair: An Assessment of its Long-term Impact on Mitral Regurgitation’ is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 hour of external CME credits. 

 

Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

 

Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionals and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website.

Instruction to Participants

There is no fee for taking part in this online learning activity.

 

Activities are designed to be completed within 60 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.

 

To complete the course and claim certification participants must:

 

  • Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.
  • Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.

Target Audience

This programme is intended to educate:

  • Interventional Cardiologists
  • Cardiothoracic Surgeons
  • General Cardiologists

Learning Objectives

Upon participation in this programme physicians should be able to:

  • Recall the long-term outcomes of TEER from real-world and RCT data
  • Apply the results of real-world data to both simple and complex patients
  • Describe how TEER is being used to benefit a range of patients with MR
Register now Log in

Module

Title

Duration

Speakers

Presentation Long-term Outcomes of TEER Paul Mahoney
Presentation Real-world Data and Simple and Complex Patients Francesco Maisano
Presentation Patient Cases Anita Asgar
Discussion Key Learnings and Close Marta Sitges
Presentation.

Long-term Outcomes of TEER

Duration:

Speakers: Paul Mahoney

Presentation.

Real-world Data and Simple and Complex Patients

Duration:

Speakers: Francesco Maisano

Presentation.

Patient Cases

Duration:

Speakers: Anita Asgar

Discussion.

Key Learnings and Close

Duration:

Speakers: Marta Sitges

Chair

Marta Sitges

Hospital Clinic, University of Barcelona

Dr Marta Sitges is a senior consultant non-invasive cardiologist at the Cardiovascular Institute in Hospital Clinic and Professor of Medicine at the University of Barcelona. She has also been the Director of the Cardiovascular Institute since October 2015.

View full profile

Speaker

Paul Mahoney

Sentara Norfolk General Hospital

Dr Paul Mahoney is a cardiologist in Norfolk, Virginia. Dr Mahoney serves as the Medical Director of the Sentara Structural Heart Program, and has as a particular focus on the diagnosis and treatment of structural heart disease.

View full profile

Francesco Maisano

San Raffaele Research Hospital, Milan, Italy

Prof Maisano is Professor of Cardiac Surgery and Director of the Valve Center at San Raffaele Research Hospital in Milan.

View full profile

Anita Asgar

Montreal Heart Institute

Dr Anita Asgar is an Interventional Cardiologist working at the Montreal Heart Institute, and Associate Professor of Medicine at the University of Montreal.

View full profile

1.00 European Board for Accreditation of Continuing Education for Health Professionals (EBAC)

Related Courses

Severe Aortic Stenosis: Stratifying Patients for Lifetime Management
  • 1 EBAC

Learning objectives

  • Describe the challenges with lifetime management in severe AS in both a SAVR and TAVI-first scenario
  • Summarise clinical evidence for TAVI in low surgical risk patients
  • Recall different guideline recommendations for SAVR and TAVI approaches
  • Assimilate current clinical knowledge with patient preferences when formulating treatment plans for severe AS patient
See more
Renal Denervation In The Real World: Practical Guidance For New Users
  • 1 EBAC

Learning objectives

  • Assess the current global burden of resistant hypertension
  • Carry out appropriate assessments to identify resistant hypertension
  • Identify patients most likely to benefit from RDN
  • Recall the practical considerations for adopting RDN into routine practice
  • Recall the latest data on RDN from recent clinical trials
See more
Getting it Right First Time in Severe Aortic Stenosis - Key insights for Long Term Success
  • 1 EBAC

Learning objectives

  • Recall current and predicted trends in TAVI with respect to preserving coronary access
  • Consider determining factors for choosing valves in low risk populations
  • Discuss solutions for maximising valve durability and haemodynamics and for treating degenerated TAVI
See more
Optimising Outcomes For The Tavi Patient: Key Considerations For First Valve Choice And Implantation Techniques

Learning objectives

  • Recall the latest data showing why durability and hemodynamics matter for initial valve selection
  • Discuss the latest techniques to help achieve optimal outcomes for patients with longer life expectancy
  • Review TAVI cases that highlight procedure optimisation with the Evolut pro+ platform
See more
Transcatheter Interventions Online - Session 3.4: Debates
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 3.3: Keynote & Controversies: Live Cases And Discussion
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 3.1 & 3.2: Keynote & Controversies
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 2.4 Practical Pearls Toward a More Advanced CTO Programme: Live Cases and Discussion
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 2.3: Practical Pearls Toward a More Advanced CTO Programme
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 2.2: Strategies For Calcified Coronary Lesions Anno 2022: Live Cases And Discussion
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more